HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

myeloma-associated membrane antigen KMA

identical to kappa light chains from HMy2 surface IgG; consists of two major and 3 minor components

Also Known As:

myeloma antigen KMA

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

1.	Multiple Myeloma 01/01/2023 - "KappaMab (KM; formerly MDX-1097) is a monoclonal antibody specific for the kappa myeloma antigen (KMA), a cell-surface antigen expressed on malignant plasma cells in kappa-restricted multiple myeloma (κMM), some lymphomas, occasional tonsillar B cells and in vitro activated B cells, but not on normal B cells in bone marrow. "
2.	Lymphoma (Lymphomas) 01/01/2023 - "KappaMab (KM; formerly MDX-1097) is a monoclonal antibody specific for the kappa myeloma antigen (KMA), a cell-surface antigen expressed on malignant plasma cells in kappa-restricted multiple myeloma (κMM), some lymphomas, occasional tonsillar B cells and in vitro activated B cells, but not on normal B cells in bone marrow. "

Related Drugs and Biologics

1.	Surface Antigens (Surface Antigen)
2.	Monoclonal Antibodies